Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19901 - 19925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	AURKB	9212	downregulated	cupric oxide results in decreased expression of AURKB mRNA	17p13.1	A21783
Cupric oxide	Approved	AXL	558	downregulated	cupric oxide results in decreased expression of AXL mRNA	19q13.2	A21783
Cupric oxide	Approved	BARD1	580	downregulated	cupric oxide results in decreased expression of BARD1 mRNA	2q35	A21783
Cupric oxide	Approved	BCAR3	8412	downregulated	cupric oxide results in decreased expression of BCAR3 mRNA	1p22.1	A21783
Cupric oxide	Approved	BCL2A1	597	downregulated	cupric oxide results in decreased expression of BCL2A1 mRNA	15q25.1	A21783
Cupric oxide	Approved	BEX2	84707	upregulated	cupric oxide results in increased expression of BEX2 mRNA	Xq22.2	A21783
Cupric oxide	Approved	BLOC1S1	2647	upregulated	cupric oxide results in increased expression of BLOC1S1 mRNA	12q13.2	A21783
Cupric oxide	Approved	BNIP3L	665	upregulated	cupric oxide results in increased expression of BNIP3L mRNA	8p21.2	A21783
Cupric oxide	Approved	BRF2	55290	upregulated	cupric oxide results in increased expression of BRF2 mRNA	8p11.23	A21783
Cupric oxide	Approved	C1S	716	upregulated	cupric oxide results in increased expression of C1S mRNA	12p13.31	A21783
Cupric oxide	Approved	CARD6	84674	upregulated	cupric oxide results in increased expression of CARD6 mRNA	5p13.1	A21783
Cupric oxide	Approved	CCDC80	151887	downregulated	cupric oxide results in decreased expression of CCDC80 mRNA	3q13.2	A21783
Cupric oxide	Approved	CCNA2	890	downregulated	cupric oxide results in decreased expression of CCNA2 mRNA	4q27	A21783
Cupric oxide	Approved	CCNB1	891	downregulated	cupric oxide results in decreased expression of CCNB1 mRNA	5q13.2	A21783
Cupric oxide	Approved	CCNB2	9133	downregulated	cupric oxide results in decreased expression of CCNB2 mRNA	15q22.2	A21783
Cupric oxide	Approved	CCNK	8812	upregulated	cupric oxide results in increased expression of CCNK mRNA	14q32.2	A21783
Cupric oxide	Approved	CDC20	991	downregulated	cupric oxide results in decreased expression of CDC20 mRNA	1p34.2	A21783
Cupric oxide	Approved	CDC40	51362	upregulated	cupric oxide results in increased expression of CDC40 mRNA	6q21	A21783
Cupric oxide	Approved	CDCA3	83461	downregulated	cupric oxide results in decreased expression of CDCA3 mRNA	12p13.31	A21783
Cupric oxide	Approved	CDK1	983	downregulated	cupric oxide results in decreased expression of CDK1 mRNA	10q21.2	A21783
Cupric oxide	Approved	CDK5R2	8941	upregulated	cupric oxide results in increased expression of CDK5R2 mRNA	2q35	A21783
Cupric oxide	Approved	CDK6	1021	downregulated	cupric oxide results in decreased expression of CDK6 mRNA	7q21.2	A21783
Cupric oxide	Approved	CDKL3	51265	upregulated	cupric oxide results in increased expression of CDKL3 mRNA	5q31.1	A21783
Cupric oxide	Approved	CDKN1B	1027	downregulated	cupric oxide results in decreased expression of CDKN1B mRNA	12p13.1	A21783
Cupric oxide	Approved	CDKN2AIP	55602	upregulated	cupric oxide results in increased expression of CDKN2AIP mRNA	4q35.1	A21783

Displaying entries 19901 - 19925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability